Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-055053
Filing Date
2006-03-15
Accepted
2006-03-15 16:28:37
Documents
10
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 923602
2 SUBSIDIARIES OF POINT THERAPEUTICS, INC. dex211.htm EX-21.1 2557
3 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 1787
4 CERTIFICATION OF DONALD R. KIEPERT, JR PURSUANT TO SECTION 302 dex311.htm EX-31.1 6601
5 CERTIFICATION OF RICHARD N. SMALL PURSUANT TO SECTION 302 dex312.htm EX-31.2 6486
6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, SECTION 906 dex321.htm EX-32.1 5863
7 GRAPHIC g78583g09g81.jpg GRAPHIC 67782
8 GRAPHIC g78583g46r58.jpg GRAPHIC 87998
9 GRAPHIC g78583g74l92.jpg GRAPHIC 57143
10 GRAPHIC g78583g90q78.jpg GRAPHIC 74379
  Complete submission text file 0001193125-06-055053.txt   1344871
Mailing Address 155 FEDERAL STREET BOSTON MA 02110
Business Address 155 FEDERAL STREET BOSTON MA 02110 6179332130
POINT THERAPEUTICS INC (Filer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23776 | Film No.: 06688601
SIC: 2834 Pharmaceutical Preparations